Position in SVRA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,720,792
+$4,538,511 QoQ
Shares Held
864,614
+981.5% QoQ
Ownership
0.422%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#35
of 184 holders
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $437,724,004 across 106 Biotechnology names. SVRA ranks #32 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
827,454 | $22,920,475 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
135,460 | $22,895,449 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
928,568 | $21,691,348 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
363,984 | $21,151,110 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
283,921 | $21,083,973 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
264,200 | $15,363,230 | |
| 7 | MRNA |
Moderna, Inc.
|
237,418 | $12,060,834 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.DE
|
563,999 | $11,031,820 |
All Filings in SVRA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,720,792 | 864,614 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $182,281 | 79,948 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $368,321 | 132,968 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $408,211 | 132,968 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $525,624 | 123,968 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $962,392 | 238,807 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $983,201 | 197,430 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $138,499 | 36,640 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $51,279 | 16,050 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||